Italian pharma Alfasigma has…
Italian pharma Alfasigma has penned a 125 million euros ($145 [...]
With Xtandi set to lose U.S….
With Xtandi set to lose U.S. patent protection next year, [...]
Hopes were high Wednesday for a…
Hopes were high Wednesday for a billion-dollar megadeal—the kind the [...]
With a White House drug pricing…
With a White House drug pricing deal done and dusted [...]
The past year was one of…
The past year was one of turbulence and change at [...]
Caldera has burst onto the scene…
Caldera has burst onto the scene with $112.5 million in [...]
The Novo Nordisk Foundation is…
The Novo Nordisk Foundation is investing 5.5 billion Danish kroner [...]
While the $80 billion revenue…
While the $80 billion revenue target AstraZeneca set for 2030 [...]
Still riding the high of last…
Still riding the high of last year’s twice-yearly HIV PrEP [...]
Ionis Pharmaceuticals’ launch of…
Ionis Pharmaceuticals’ launch of Tryngolza (olezarsen) is off to a [...]